Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer

The type of patients with stage III non-small-cell lung cancer (NSCLC) selected for concurrent chemoradiotherapy (cCRT) varies between and within countries, with higher-volume centres treating patients with more co-morbidities and higher-stage disease. However, in spite of these disease characterist...

Descripción completa

Detalles Bibliográficos
Autores principales: Storey, Claire L., Hanna, Gerard G., Greystoke, Alastair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735214/
https://www.ncbi.nlm.nih.gov/pubmed/33293673
http://dx.doi.org/10.1038/s41416-020-01072-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735214/
https://www.ncbi.nlm.nih.gov/pubmed/33293673
http://dx.doi.org/10.1038/s41416-020-01072-4

Ejemplares similares